Cargando…
Extended half‐life rFIX in major surgery—How to improve clinical practice: An intraindividual comparison
Practical, safe, and effective hemostatic approach to orthopedic surgery using Extended Half‐Life factor IX in hemophilia B. By intraindividual comparison, we found a lower FIX consumption, number of infusions, and cost compared to plasma‐derived FIX.
Autores principales: | Valeri, Federica, Agnelli Giacchello, Jacopo, Dainese, Cristina, Valpreda, Alessandra, Montaruli, Barbara, Dosio, Enrico, Boccadoro, Mario, Borchiellini, Alessandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069879/ https://www.ncbi.nlm.nih.gov/pubmed/32185052 http://dx.doi.org/10.1002/ccr3.2450 |
Ejemplares similares
-
ADAMTS13 Autoantibodies and Burden of Care in Immune Thrombotic Thrombocytopenic purpura: New Evidence and Future Implications
por: Dainese, Cristina, et al.
Publicado: (2022) -
Management of patients with bleeding disorders and educational needs regarding hemophilia a in 23 Italian emergency departments – Results from a survey conducted in Piedmont
por: Pollio, Berardino, et al.
Publicado: (2022) -
Real-Life Pharmacokinetics of rFVIII-Fc and rFIX-Fc
por: Traets, Marissa J.M., et al.
Publicado: (2020) -
Impact of COVID-19 Infection, Vaccination, and Serological Response in Immune Thrombocytopenic Purpura Patients: A Single-Center Global Analysis
por: Dainese, Cristina, et al.
Publicado: (2022) -
Surgery and Prophylaxis with Susoctocog-Alfa in Acquired Hemophilia: Case Series and Literature Review
por: Sella, Carola, et al.
Publicado: (2023)